Natera Inc (NTRA)
125.72
+1.87
(+1.51%)
USD |
NASDAQ |
Sep 27, 16:00
125.70
-0.02
(-0.02%)
After-Hours: 20:00
Natera Research and Development Expense (Annual): 320.68M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 320.68M |
| December 31, 2022 | 316.42M |
| December 31, 2021 | 264.21M |
| December 31, 2020 | 100.04M |
| December 31, 2019 | 51.36M |
| December 31, 2018 | 51.36M |
| Date | Value |
|---|---|
| December 31, 2017 | 50.06M |
| December 31, 2016 | 41.86M |
| December 31, 2015 | 27.71M |
| December 31, 2014 | 17.29M |
| December 31, 2013 | 11.55M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
51.36M
Minimum
2019
320.68M
Maximum
2023
210.54M
Average
264.21M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Danaher Corp | 1.503B |
| Exact Sciences Corp | 425.88M |
| Illumina Inc | 1.354B |
| Mettler-Toledo International Inc | 185.28M |
| Castle Biosciences Inc | 53.62M |